Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2713)
All Articles published online
|
Jun 7, 2006 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Legan M, Luzar B, Marolt VF, Cör A. Expression of cyclooxygenase-2 is associated with p53 accumulation in premalignant and malignant gallbladder lesions. World J Gastroenterol 2006; 12(21): 3425-3429 [PMID: 16733863 DOI: 10.3748/wjg.v12.i21.3425] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i21/3425.htm |
| Number | Citing Articles |
| 1 |
Minsub Shim, Julie Foley, Colleen Anna, Yuji Mishina, Thomas Eling. Embryonic Expression of Cyclooxygenase-2 Causes Malformations in Axial Skeleton. Journal of Biological Chemistry 2010; 285(21): 16206 doi: 10.1074/jbc.M109.078576
|
| 2 |
Agnès Maillet, Shazib Pervaiz. Redox Regulation of p53, Redox Effectors Regulated by p53: A Subtle Balance. Antioxidants & Redox Signaling 2012; 16(11): 1285 doi: 10.1089/ars.2011.4434
|
| 3 |
Chong-Fei Huang, Jun-Jun Huang, Ning-Ning Mi, Yan-Yan Lin, Qiang-Sheng He, Ya-Wen Lu, Ping Yue, Bing Bai, Jin-Duo Zhang, Chao Zhang, Teng Cai, Wen-Kang Fu, Long Gao, Xun Li, Jin-Qiu Yuan, Wen-Bo Meng. Associations between serum uric acid and hepatobiliary-pancreatic cancer: A cohort study. World Journal of Gastroenterology 2020; 26(44): 7061-7075 doi: 10.3748/wjg.v26.i44.7061
|
| 4 |
Deepika Dhawan, Antonella Borgatti Jeffreys, Rong Zheng, Jane C. Stewart, Deborah W. Knapp. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Molecular Cancer Therapeutics 2008; 7(4): 897 doi: 10.1158/1535-7163.MCT-07-0313
|
| 5 |
Marketa Hermanova, Jan Trna, Rudolf Nenutil, Petr Dite, Zdenek Kala. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions. European Journal of Gastroenterology & Hepatology 2008; 20(8): 732 doi: 10.1097/MEG.0b013e3282f945fb
|
| 6 |
Do‐Hee Kim, Joydeb Kumar Kundu, Young‐Joon Surh. Redox modulation of p53: Mechanisms and functional significance. Molecular Carcinogenesis 2011; 50(4): 222 doi: 10.1002/mc.20709
|
| 7 |
Hou-Shan Yao, Chang Sun, Xin-Xing Li, Yi Wang, Kai-Zhou Jin, Xiao-Ping Zhang, Zhi-Qian Hu. Annexin A4-nuclear factor-κB feedback circuit regulates cell malignant behavior and tumor growth in gallbladder cancer. Scientific Reports 2016; 6(1) doi: 10.1038/srep31056
|
| 8 |
Juan Carlos Roa, Nora Katabi, N. Volkan Adsay. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 891 doi: 10.1007/978-1-4419-7107-4_61
|
| 9 |
Erdenebulgan Batmunkh, Mitsuo Shimada, Yuji Morine, Satoru Imura, Hirofumi Kanemura, Yusuke Arakawa, Jun Hanaoka, Mami Kanamoto, Koji Sugimoto, Masaaki Nishi. Expression of hypoxia-inducible factor-1 alpha (HIF-1α) in patients with the gallbladder carcinoma. International Journal of Clinical Oncology 2010; 15(1): 59 doi: 10.1007/s10147-009-0011-7
|
| 10 |
Mateja Legan, Boštjan Luzar, Vera Ferlan Marolt. Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis. Scandinavian Journal of Gastroenterology 2009; 44(9): 1101 doi: 10.1080/00365520903121685
|
| 11 |
Eduardo E. Montalvo-Jave, Amir A. Rahnemai- Azar, Dimitrios Papaconstantinou, Mariana Espejel Deloiza, Diamantis I. Tsilimigras, Dimitrios Moris, German Eduardo Mendoza-Barrera, Sharon M. Weber, Timothy M. Pawlik. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surgical Oncology 2019; 31: 83 doi: 10.1016/j.suronc.2019.09.006
|
| 12 |
Deepika Dhawan, Bruce A. Craig, Liang Cheng, Paul W. Snyder, Sulma I. Mohammed, Jane C. Stewart, Rong Zheng, Rhoda A. Loman, Richard S. Foster, Deborah W. Knapp. Effects of Short-term Celecoxib Treatment in Patients with Invasive Transitional Cell Carcinoma of the Urinary Bladder. Molecular Cancer Therapeutics 2010; 9(5): 1371 doi: 10.1158/1535-7163.MCT-10-0049
|
| 13 |
Juan Carlos Roa, N. Volkan Adsay. Molecular Surgical Pathology. 2013; : 65 doi: 10.1007/978-1-4614-4900-3_4
|
| 14 |
Eric I Marks, Nelson S Yee. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World Journal of Gastroenterology 2016; 22(4): 1335-1347 doi: 10.3748/wjg.v22.i4.1335
|
| 15 |
Guo-shun Shu, Fang Lv, Zhu-lin Yang, Xiong-ying Miao. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. International Journal of Clinical Oncology 2013; 18(4): 641 doi: 10.1007/s10147-012-0431-7
|
| 16 |
Bridget C. Lynch, Sarah L. Lathrop, Dongmei Ye, Thomas Y. Ma, Lisa A. Cerilli. Expression of the p16(INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladder. Annals of Diagnostic Pathology 2008; 12(3): 161 doi: 10.1016/j.anndiagpath.2007.06.003
|
| 17 |
Jaime A. Espinoza, Carolina Bizama, Patricia García, Catterina Ferreccio, Milind Javle, Juan F. Miquel, Jill Koshiol, Juan C. Roa. The inflammatory inception of gallbladder cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016; 1865(2): 245 doi: 10.1016/j.bbcan.2016.03.004
|
| 18 |
Emanuela de Moraes, Nazir Ahmad Dar, Claudia Vitoria de Moura Gallo, Pierre Hainaut. Cross‐talks between cyclooxygenase‐2 and tumor suppressor protein p53: Balancing life and death during inflammatory stress and carcinogenesis. International Journal of Cancer 2007; 121(5): 929 doi: 10.1002/ijc.22899
|
| 19 |
Jorge Albores-Saavedra, Arturo Angeles-Angeles. MacSween's Pathology of the Liver. 2012; : 563 doi: 10.1016/B978-0-7020-3398-8.00011-8
|
| 20 |
Maria Diab, Philip A. Philip. Textbook of Gastrointestinal Oncology. 2019; : 197 doi: 10.1007/978-3-030-18890-0_12
|
| 21 |
|
| 22 |
James F. Watkins, Matthew S. Mayo, Holly J. Smith, Stephen K. Williamson. Gemcitabine, irinotecan and celecoxib in patients with biliary cancer. Anti-Cancer Drugs 2009; 20(4): 294 doi: 10.1097/CAD.0b013e3283287ca0
|
| 23 |
Xiaoling Song, Yunping Hu, Yongsheng Li, Rong Shao, Fatao Liu, Yingbin Liu. Overview of current targeted therapy in gallbladder cancer. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00324-2
|
| 24 |
Robert David Goldin, Juan Carlos Roa. Gallbladder cancer: a morphological and molecular update. Histopathology 2009; 55(2): 218 doi: 10.1111/j.1365-2559.2008.03192.x
|
| 25 |
Sung-Im Do, Gou Young Kim, Sung-Jig Lim, Youn Wha Kim. Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision-Like Protein HuR in Gallbladder Carcinoma. The Korean Journal of Pathology 2010; 44(1): 42 doi: 10.4132/KoreanJPathol.2010.44.1.42
|
| 26 |
S.G. Barreto, A. Dutt, A. Chaudhary. A genetic model for gallbladder carcinogenesis and its dissemination. Annals of Oncology 2014; 25(6): 1086 doi: 10.1093/annonc/mdu006
|
| 27 |
Ioannis S. Pateras, Ana Igea, Ilias P. Nikas, Danai Leventakou, Nektarios I. Koufopoulos, Argyro Ioanna Ieronimaki, Anna Bergonzini, Han Suk Ryu, Antonios Chatzigeorgiou, Teresa Frisan, Christos Kittas, Ioannis G. Panayiotides. Diagnostic Challenges during Inflammation and Cancer: Current Biomarkers and Future Perspectives in Navigating through the Minefield of Reactive versus Dysplastic and Cancerous Lesions in the Digestive System. International Journal of Molecular Sciences 2024; 25(2): 1251 doi: 10.3390/ijms25021251
|